ClinicalTrials.gg
CompletedNCT07844564Updated Sep 28, 2026

Effects of Nonsurgical Periodontal Treatment on GCF Calprotectin and IL-10 in Rheumatoid Arthritis

An interventional study of Non-surgical Periodontal Treatment in Rheumatoid Arthritis (RA), Periodontitis and Gingivitis, sponsored by Ondokuz Mayıs University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Ondokuz Mayıs University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Jul 2025, registered Sep 2026).
Updated Sep 28, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 128 studies in Arthritis, Rheumatoid with a site in Turkey — 14 open to participants now, 19 under way, 2 of them phase 3. Arthritis, Rheumatoid · Turkey.

Enrollment
55th of 78
54 · median 77
Started
2025
with 17 others
No phase
44 of 128
5 open now
Registered
125th of 128
by date

Among the 128 studies in Arthritis, Rheumatoid with a site in Turkey, this one is the 55th largest by enrollment of the 78 interventional ones that give a count, is one of 18 that started in 2025, is one of 44 with no phase, and was the 125th registered.

Arthritis, Rheumatoid

3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.

Browse Arthritis, Rheumatoid studies →

Open to participants now

14 of the 128 studies in Arthritis, Rheumatoid with a site in Turkey are open now. Recruiting first, the newest first:

9 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 128 studies in Arthritis, Rheumatoid with a site in Turkey, or all of them as a file.
02

Study summary

This study evaluates the relationship between rheumatoid arthritis and periodontal health and examines the effects of nonsurgical periodontal treatment on clinical periodontal findings and gingival crevicular fluid biomarkers. Participants with and without rheumatoid arthritis were classified according to periodontal status as periodontally healthy, gingivitis, or periodontitis. Clinical periodontal measurements and gingival crevicular fluid levels of calprotectin (MRP-8/14) and interleukin-10 (IL-10) were evaluated at baseline, 1 month, and 3 months. Disease Activity Score-28 (DAS28) was also evaluated in participants with rheumatoid arthritis.

03

Conditions studied

  • Rheumatoid Arthritis (RA)
  • Periodontitis
  • Gingivitis

Keywords

  • Nonsurgical Periodontal Treatment
  • Gingival Crevicular Fluid
  • Calprotectin
  • MRP-8/14
  • Interleukin-10
  • IL-10
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Voluntary participation in the study. Aged 18 to 65 years. For participants in the rheumatoid arthritis groups, diagnosis of rheumatoid arthritis at least 1 year before enrollment.

For participants in the systemically healthy groups, absence of any systemic disease that may affect periodontal tissues.

No periodontal treatment within the previous 6 months. No local or systemic antibiotic use within the previous 3 months. Never having smoked or having stopped smoking at least 2 years before enrollment.

For participants in the periodontally healthy control groups, no history of periodontal disease and the presence of good oral hygiene.

Exclusion criteria

Exclusion Criteria:

Unwillingness to participate in the study. Age younger than 18 years or older than 65 years. Presence of any systemic disease other than rheumatoid arthritis that may affect periodontal tissues.

Local or systemic antibiotic use within the previous 3 months. Periodontal treatment within the previous 6 months. Pregnancy or lactation. Use of medications that may affect gingival tissues, including calcium channel blockers, phenytoin, cyclosporine, or hormone replacement therapy.

Receiving biological treatment for rheumatoid arthritis, such as anti-tumor necrosis factor therapy.

Current smoking.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    Periodontitis with Rheumatoid Arthritis (P+RA

    Participants with rheumatoid arthritis and periodontitis receive non-surgical periodontal treatment. This arm includes 9 participants.

    Procedure: Non-surgical Periodontal Treatment

  • Experimental
    Systemically Healthy Participants with Periodontitis (P)

    Systemically healthy participants with periodontitis receive non-surgical periodontal treatment. This arm includes 9 participants.

    Procedure: Non-surgical Periodontal Treatment

  • Experimental
    Gingivitis with Rheumatoid Arthritis (G+RA)

    Participants with rheumatoid arthritis and gingivitis receive non-surgical periodontal treatment. This arm includes 9 participants.

    Procedure: Non-surgical Periodontal Treatment

  • Experimental
    Systemically Healthy Participants with Gingivitis (G)

    Systemically healthy participants with gingivitis receive non-surgical periodontal treatment. This arm includes 9 participants.

    Procedure: Non-surgical Periodontal Treatment

  • No intervention
    Periodontally Healthy Participants with Rheumatoid Arthritis (S+RA)

    Participants with rheumatoid arthritis and periodontal health receive no periodontal treatment and serve as a comparison group. This arm includes 9 participants.

  • No intervention
    Systemically Healthy Participants with Periodontal Health (S)

    Systemically and periodontally healthy participants receive no periodontal treatment and serve as a comparison group. This arm includes 9 participants.

Interventions

  • ProcedureNon-surgical Periodontal Treatment

    The intervention consists of oral hygiene instructions, full-mouth scaling, and subgingival instrumentation and root planing where clinically indicated. It is administered to participants with periodontitis or gingivitis after baseline assessments. Periodontally healthy groups receive no periodontal treatment.

    Also known as: NSPT

06

What researchers measure

Primary outcomes

  1. Change in Gingival Crevicular Fluid Calprotectin (MRP-8/14) Levels

    Gingival crevicular fluid calprotectin (MRP-8/14) levels were measured using an enzyme-linked immunosorbent assay (ELISA). Changes in calprotectin levels were evaluated over time and compared according to rheumatoid arthritis status and periodontal condition.

    Time frame: Baseline, 1 month, and 3 months

Secondary outcomes

  1. Change in Gingival Crevicular Fluid Interleukin-10 (IL-10) Levels

    Gingival crevicular fluid interleukin-10 (IL-10) levels were measured using an enzyme-linked immunosorbent assay (ELISA). Changes in IL-10 levels were evaluated over time and compared according to rheumatoid arthritis status and periodontal condition.

    Time frame: Baseline, 1 month, and 3 months

  2. Change in Probing Pocket Depth

    Probing pocket depth was measured in millimeters using a periodontal probe as the distance from the gingival margin to the base of the periodontal pocket. Changes were evaluated over time according to rheumatoid arthritis status and periodontal condition.

    Time frame: Baseline, 1 month, and 3 months

  3. Change in Clinical Attachment Level

    Clinical attachment level was measured in millimeters using a periodontal probe as the distance from the cementoenamel junction to the base of the periodontal pocket. Changes were evaluated over time according to rheumatoid arthritis status and periodontal condition.

    Time frame: Baseline, 1 month, and 3 months

  4. Change in Bleeding on Probing

    Bleeding on probing was recorded as present or absent following gentle periodontal probing and expressed as the percentage of sites with bleeding. Changes were evaluated over time according to rheumatoid arthritis status and periodontal condition.

    Time frame: Baseline, 1 month, and 3 months

  5. Change in Plaque Index

    Plaque accumulation was assessed using the Plaque Index. Changes in plaque scores were evaluated over time according to rheumatoid arthritis status and periodontal condition.

    Time frame: Baseline, 1 month, and 3 months

  6. Change in Gingival Index

    Gingival inflammation was assessed using the Gingival Index. Changes in gingival index scores were evaluated over time according to rheumatoid arthritis status and periodontal condition.

    Time frame: Baseline, 1 month, and 3 months

  7. Change in Gingival Crevicular Fluid Volume

    Gingival crevicular fluid volume was measured using Periopaper strips and a calibrated Periotron 8000 device. Changes in gingival crevicular fluid volume were evaluated over time according to rheumatoid arthritis status and periodontal condition.

    Time frame: Baseline, 1 month, and 3 months

  8. Change in Disease Activity Score-28 (DAS28)

    Disease activity was evaluated in participants with rheumatoid arthritis using the Disease Activity Score-28 (DAS28). Changes in DAS28 scores were assessed following nonsurgical periodontal treatment.

    Time frame: Baseline and 3 months

07

Study locations

1 site
  • Ondokuz Mayis University Faculty of Dentistry
    Samsun, Samsun 55200, Turkey (Türkiye)
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in May 2026, 9 months.

Of 293 non-industry interventional studies with no phase under Arthritis, Rheumatoid, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 39. This study's 9 months is below that.

Counting every sponsor, half of 349 studies reached it within 27 months; a quarter within 13 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2026
First posted
Sep 28, 2026
StartActual
Jul 17, 2025
Primary completionActual
May 11, 2026
CompletionActual
May 11, 2026
Last update
Sep 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 28, 2026
Show all 1 update
  1. Sep 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07844564
Responsible party
Songül Bingöl (Research Assistant, Department of Periodontology, Faculty of Dentistry, Ondokuz Mayıs University) — Principal investigator
First posted
Sep 28, 2026
Start date
Jul 17, 2025
Primary completion
May 11, 2026
Completion
May 11, 2026
Last update
Sep 28, 2026

Study contacts

Songül Bingöl, DDS
principal investigator · Ondokuz Mayis University, Faculty of Dentistry, Department of Periodontology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion